Myo-Inositol for Pcos Support

Research suggests that myo-inositol may offer benefits for women with PCOS during pregnancy, though direct, high-quality evidence specific to this population remains limited. The available evidence base consists of a single published trial protocol — the MYPP trial, a multicenter, double-blind randomized controlled trial — which has not yet reported results. The protocol was motivated by earlier trials in broader populations suggesting myo-inositol could reduce rates of gestational diabetes and preterm birth, with post-hoc analyses hinting at stronger effects in women with PCOS specifically, but those findings were exploratory rather than definitive. Until the MYPP trial and similar focused studies are completed, conclusions about myo-inositol's benefits for PCOS during pregnancy remain preliminary, and the current evidence is insufficient to draw firm determinations.